KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Debt Ratio (2018 - 2022)

TherapeuticsMD (TXMD) has disclosed Debt Ratio for 6 consecutive years, with 0.7 as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Debt Ratio fell 21.53% year-over-year to 0.7, compared with a TTM value of 0.7 through Sep 2022, down 21.53%, and an annual FY2021 reading of 1.11, down 15.12% over the prior year.
  • Debt Ratio was 0.7 for Q3 2022 at TherapeuticsMD, up from 0.62 in the prior quarter.
  • Across five years, Debt Ratio topped out at 1.52 in Q1 2022 and bottomed at 0.31 in Q3 2018.
  • Average Debt Ratio over 5 years is 0.83, with a median of 0.79 recorded in 2019.
  • The sharpest move saw Debt Ratio soared 153.65% in 2019, then plummeted 33.38% in 2021.
  • Year by year, Debt Ratio stood at 0.35 in 2018, then skyrocketed by 111.39% to 0.73 in 2019, then surged by 78.86% to 1.31 in 2020, then fell by 15.12% to 1.11 in 2021, then crashed by 37.08% to 0.7 in 2022.
  • Business Quant data shows Debt Ratio for TXMD at 0.7 in Q3 2022, 0.62 in Q2 2022, and 1.52 in Q1 2022.